SEC Form 4 · accession 0001192482-16-000648
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A. Fallon
Director
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $16.49 | Jun 9, 2016 | A | 15,000 | A | — | Jun 9, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable over a four-year period commencing on June 9, 2016. Twenty-five percent (25%) of the option vests and becomes exercisable on June 9, 2017, and the balance vests in equal monthly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the director's continued service with the issuer.